Table 3.
Comparison of optimal and actual chemotherapy utilisation rates for upper gastrointestinal cancers.
| Tumour site | Optimal chemotherapy utilisation rate (%) | Actual chemotherapy utilisation rate (%) | |||
|---|---|---|---|---|---|
| Any time | First course treatment | United States NCDB [1, 8–11, 13] |
United Kingdom NYCRIS [16] |
Sweden [12] |
|
| Oesophagus | 79 | 57 | 38–52 | 15 | NR |
| Stomach | 83 | 83 | 34 | 14 | 10–20 |
| Pancreas | 35 | 35 | 19–37 | 11 | 20–30 |
| Primary liver | 27 | 22 | 22–37 | NR | NR |
| Gallbladder | 80 | 33 | 22 | NR | NR |
NCDB: National Cancer Database, NYCRIS: Northern and Yorkshire Cancer Registry, and NR: not reported.